Diemazz

Niaprazine
Systematic (IUPAC) name
N-[4-[4-(4-fluorophenyl)piperazin-1-yl]butan-2-yl]pyridine-3-carboxamide
Identifiers
CAS number	27367-90-4
ATC code	N05CM16
PubChem	71919
Chemical data
Formula	C20H25FN4O
Mol. mass	356.437
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	4.53 hours (± 0.86)
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status	℞-only(US)
Routes	Oral

Niaprazine (Nopron) is a piperazine derivative drug which acts as a sedating antihistamine. It was invented in the 1970s ^[1], and is used in France, Italy and other European countries. It is mainly prescribed for its relatively strong sedative effects rather than as an antihistamine, and is used mainly for treating autism ^[2] and insomnia ^[3] in children and adolescents.

Side effects

Common side effects are: sedation during the day (especially during the first few days of treatment) and dizziness. Less common side effect is headache during the day.

Method of Action

Niaprazine is a potent antagonist of the Histamine H1 receptor and is also an agonist at the serotonin receptors 5HT_1A, 5HT_2A and 5HT_2C via its metabolite pFPP. Niaprazine enhances slow wave sleep.^[4]

References

1. ^ Duchene-Marullaz P, Rispat G, Perriere JP, Hache J, Labrid C. Some pharmacodynamical properties of niaprazine, a new antihistaminic agent. (French) Therapie. 1971 Nov-Dec;26(6):1203-9.
2. ^ Rossi PG, Posar A, Parmeggiani A, Pipitone E, D'Agata M. Niaprazine in the treatment of autistic disorder. Journal of Child Neurology. 1999 Aug;14(8):547-50.
3. ^ Younus M, Labellarte MJ. Insomnia in children: when are hypnotics indicated? Paediatric Drugs. 2002;4(6):391-403.
4. ^ ZUCCONI et al. 1988, KALES: The pharmacology of sleep, 1995

Site Map: RSS 2.0

Recent Searches: Niaprazine
the zone diet tips2008
Category:1279 births

video the tube
soukous stars
WIKY
cz 452 magazine
September 8
Aestii

Related Pages: